Stock events for Nutex Health, Inc. (NUTX)
The past six months have included a stock plunge following a Q4 2025 earnings report that revealed a sharp revenue decline, attributed to a $55 million write-down of arbitration claims, leading to investigations by securities law firms. There have been instances of stock recovery, and insider transactions and a $25 million share repurchase program were announced in March 2026.
Demand Seasonality affecting Nutex Health, Inc.’s stock price
The demand for Nutex Health's products and services does not appear to be subject to strong seasonality. The company benefits from demographic trends, such as the aging U.S. population, and shifts in consumer preferences towards accessible and cost-effective healthcare.
Overview of Nutex Health, Inc.’s business
Nutex Health, Inc. is a healthcare services and operations company based in Houston, Texas, operating through its Hospital and Population Health Management (PHM) Divisions. The Hospital Division develops and operates healthcare models like micro-hospitals, while the PHM Division manages provider networks and offers a technology platform for optimizing care delivery. The company operates in the Healthcare sector, specifically within Medical Care Facilities or Medical Services.
NUTX’s Geographic footprint
As of March 2026, Nutex Health's Hospital Division owns and operates 27 facilities across 12 states in the United States and is headquartered in Houston, Texas.
NUTX Corporate Image Assessment
Nutex Health's brand reputation has been negatively impacted by the fallout from its Q4 2025 financial results, including a revenue miss and a significant write-down of arbitration claims, leading to investigations by securities law firms into potential fraud and federal securities law violations.
Ownership
Nutex Health, Inc. has a diverse ownership structure, with 37.67% held by institutional shareholders and a substantial 24,650.64% held by Nutex Health insiders. Major institutional owners include Topline Capital Management, LLC, Pertento Partners LLP, BlackRock, Inc., Vanguard Group Inc, American Century Companies Inc, State Street Corp, Geode Capital Management, Llc, Millennium Management Llc, Morgan Stanley, and UBS Group AG. The largest individual shareholder is Thomas T. Vo, who owns 1.35 billion shares, representing 19,336.13% of the company.
Ask Our Expert AI Analyst
Price Chart
$107.64